<p>Alignment Healthcare, Inc.（纳斯达克代码：ALHC - 获取免费报告）的股票在周四下跌了 4.3%，原因是公司内部人士出售了股票。该股最低交易价为 14.33 美元，最后交易价为 14.67 美元。在午盘交易中，共交易了 1,046,953 股，较平均交易量 1,912,671 股下降了 45%。该股此前收盘价为 15.33 美元。</p>
<p>获取 <strong>Alignment Healthcare</strong> 的提醒：</p>
<p>具体来说，董事 Atlantic（Aln Hlth）L. General 在 5 月 19 日（星期一）出售了 17,000,000 股公司的股票，交易价格为每股 15.28 美元，总价值为 259,760,000.00 美元。交易完成后，该董事现在持有 44,302,175 股公司的股票，价值 676,937,234 美元。这笔交易代表了他们持股比例的 27.73% 的减少。该出售在向 SEC 的文件中披露，文件可通过此链接查看。</p>
<h2>分析师设定新目标价</h2>
<p>几位股票研究分析师最近对该公司发布了报告。Stephens 在 2 月 24 日（星期一）的研究报告中重申了 “增持” 评级，并对 Alignment Healthcare 的股票设定了 17.00 美元的目标价。Piper Sandler 在 3 月 4 日（星期二）的报告中将 Alignment Healthcare 的目标价从 14.00 美元上调至 21.00 美元，并给予该股 “增持” 评级。摩根大通将 Alignment Healthcare 的目标价从 14.00 美元上调至 17.00 美元，并在 3 月 6 日（星期四）的研究报告中给予该公司 “中性” 评级。Stifel Nicolaus 在 4 月 8 日（星期二）的研究报告中将 Alignment Healthcare 的目标价从 18.00 美元上调至 23.00 美元，并给予该公司 “买入” 评级。最后，巴克莱在 2 月 28 日（星期五）的研究报告中将 Alignment Healthcare 的目标价从 8.00 美元上调至 9.00 美元，并给予该公司 “减持” 评级。一位股票研究分析师对该股给予了卖出评级，三位给予了持有评级，七位给予了买入评级，一位给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，平均目标价为 17.17 美元。</p>
<p><strong>查看我们对 Alignment Healthcare 的最新股票分析</strong></p>
<h2>Alignment Healthcare 的价格表现</h2>
<p>该公司的 50 日简单移动平均线为 17.31 美元，200 日简单移动平均线为 14.63 美元。该公司的速动比率为 1.60，流动比率为 1.60，债务与股本比率为 1.82。该股的市值为 29.1 亿美元，市盈率为-19.09，贝塔值为 1.32。</p>
<p>Alignment Healthcare（纳斯达克代码：ALHC - 获取免费报告）最近于 5 月 1 日（星期四）发布了季度财报。该公司报告的每股收益（EPS）为-0.05 美元，超过了市场共识预期的-0.12 美元，超出幅度为 0.07 美元。Alignment Healthcare 的股本回报率为-108.69%，净利润率为-5.84%。该公司在本季度的收入为 9.2693 亿美元，而市场共识预期为 8.8983 亿美元。在去年同期，该公司的每股收益为-0.25 美元。该公司的收入同比增长了 47.5%。股票研究分析师预测，Alignment Healthcare, Inc.在当前年度的每股收益将为-0.69 美元。</p>
<h2>Alignment Healthcare 的机构交易</h2>
<p>一些机构投资者和对冲基金最近调整了对 ALHC 的持股。Wellington Management Group LLP 在第四季度将其在 Alignment Healthcare 的持股增加了 77.9%。Wellington Management Group LLP 目前持有 7,438,500 股该公司的股票，价值 83,683,000 美元，此前在上个季度增持了 3,257,630 股。T. Rowe Price Investment Management Inc.在第四季度将其在 Alignment Healthcare 的持股增加了 54.7%。T. Rowe Price Investment Management Inc.目前持有 8,649,042 股该公司的股票，价值 97,302,000 美元，此前在上个季度增持了 3,059,596 股。Millennium Management LLC 在第四季度将其在 Alignment Healthcare 的持股增加了 588.3%。Millennium Management LLC 目前持有 3,388,602 股该公司的股票，价值 38,122,000 美元，此前在该期间增持了 2,896,311 股。Point72 Asset Management L.P.在第四季度获得了 Alignment Healthcare 的新股份，价值约为 20,087,000 美元。最后，Invesco Ltd.在第一季度将其在 Alignment Healthcare 的持股增加了 1,415.7%。Invesco Ltd.目前持有 1,875,790 股该公司的股票，价值 34,927,000 美元，此前在上个季度增持了 1,752,033 股。目前 86.19% 的股票由机构投资者和对冲基金持有。</p>
<h2>关于 Alignment Healthcare</h2>
<p>（获取免费报告）</p>
<p>Alignment Healthcare, Inc.是一家技术驱动的医疗保险优势公司，为美国的老年人运营以消费者为中心的医疗保健平台。它通过其医疗保险优势计划提供定制的医疗保健，以满足各种老年人的需求。该公司成立于 2013 年，总部位于加利福尼亚州橙县。</p>
<h2>阅读更多</h2>
<ul>
<li>我们更喜欢的五只股票超过 Alignment Healthcare</li>
<li>纽约证券交易所股票为投资者提供多种优质选择</li>
<li>这四位顶级投资者在第一季度购买了超过 600 万股博通股票</li>
<li>三只股票保护您的投资组合免受冠状病毒传播的影响</li>
<li>买入低位？三只油股有望大幅反弹</li>
<li>恒生指数是什么？</li>
<li>Archer 反驳空头，指出强劲的第一季度及全球势头</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Alignment Healthcare 吗？</h2>
<p>在考虑 Alignment Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前购买……而 Alignment Healthcare 并不在名单上。</p>
<p>虽然 Alignment Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ALHC

<p>Alignment Healthcare（纳斯达克代码：ALHC）的股价下跌了 4.3%，原因是内部人士以每股 15.28 美元出售了 1700 万股，减少了 27.73% 的持股比例。该股票的交易区间为 14.33 美元至 14.67 美元，成交量下降了 45%。分析师的评级不一，价格目标范围从 9.00 美元到 23.00 美元不等。公司报告的年同比收入增长为 47.5%，季度每股收益为-0.05 美元，超出预期。机构投资者持有 86.19% 的股份，显示出强烈的机构兴趣</p>

<p>Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) traded down 4.3% on Thursday after an insider sold shares in the company. The stock traded as low as $14.33 and last traded at $14.67. 1,046,953 shares were traded during mid-day trading, a decline of 45% from the average session volume of 1,912,671 shares. The stock had previously closed at $15.33.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.（纳斯达克代码：ALHC - 获取免费报告）的股票在周四下跌了 4.3%，原因是公司内部人士出售了股票。该股最低交易价为 14.33 美元，最后交易价为 14.67 美元。在午盘交易中，共交易了 1,046,953 股，较平均交易量 1,912,671 股下降了 45%。该股此前收盘价为 15.33 美元。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Alignment Healthcare</strong> 的提醒：</p>
</div><p>Specifically, Director Atlantic (Aln Hlth) L. General sold 17,000,000 shares of the firm's stock in a transaction on Monday, May 19th. The stock was sold at an average price of $15.28, for a total value of $259,760,000.00. Following the completion of the sale, the director now owns 44,302,175 shares of the company's stock, valued at $676,937,234. This trade represents a 27.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link.</p>
<div class="lb-trans"><p>具体来说，董事 Atlantic（Aln Hlth）L. General 在 5 月 19 日（星期一）出售了 17,000,000 股公司的股票，交易价格为每股 15.28 美元，总价值为 259,760,000.00 美元。交易完成后，该董事现在持有 44,302,175 股公司的股票，价值 676,937,234 美元。这笔交易代表了他们持股比例的 27.73% 的减少。该出售在向 SEC 的文件中披露，文件可通过此链接查看。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several equities research analysts recently issued reports on the company. Stephens reissued an &#34;overweight&#34; rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Monday, February 24th. Piper Sandler raised their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an &#34;overweight&#34; rating in a report on Tuesday, March 4th. JPMorgan Chase &amp; Co. boosted their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a &#34;neutral&#34; rating in a research report on Thursday, March 6th. Stifel Nicolaus upped their price objective on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a &#34;buy&#34; rating in a research note on Tuesday, April 8th. Finally, Barclays lifted their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an &#34;underweight&#34; rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of &#34;Moderate Buy&#34; and an average price target of $17.17.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对该公司发布了报告。Stephens 在 2 月 24 日（星期一）的研究报告中重申了 “增持” 评级，并对 Alignment Healthcare 的股票设定了 17.00 美元的目标价。Piper Sandler 在 3 月 4 日（星期二）的报告中将 Alignment Healthcare 的目标价从 14.00 美元上调至 21.00 美元，并给予该股 “增持” 评级。摩根大通将 Alignment Healthcare 的目标价从 14.00 美元上调至 17.00 美元，并在 3 月 6 日（星期四）的研究报告中给予该公司 “中性” 评级。Stifel Nicolaus 在 4 月 8 日（星期二）的研究报告中将 Alignment Healthcare 的目标价从 18.00 美元上调至 23.00 美元，并给予该公司 “买入” 评级。最后，巴克莱在 2 月 28 日（星期五）的研究报告中将 Alignment Healthcare 的目标价从 8.00 美元上调至 9.00 美元，并给予该公司 “减持” 评级。一位股票研究分析师对该股给予了卖出评级，三位给予了持有评级，七位给予了买入评级，一位给予了强烈买入评级。根据 MarketBeat.com 的数据，该公司的平均评级为 “适度买入”，平均目标价为 17.17 美元。</p>
</div><p><strong>Check Out Our Latest Stock Analysis on Alignment Healthcare</strong></p>
<div class="lb-trans"><p><strong>查看我们对 Alignment Healthcare 的最新股票分析</strong></p>
</div><h2>Alignment Healthcare Price Performance</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的价格表现</h2>
</div><p>The company's 50-day simple moving average is $17.31 and its 200 day simple moving average is $14.63. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a market capitalization of $2.91 billion, a price-to-earnings ratio of -19.09 and a beta of 1.32.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 17.31 美元，200 日简单移动平均线为 14.63 美元。该公司的速动比率为 1.60，流动比率为 1.60，债务与股本比率为 1.82。该股的市值为 29.1 亿美元，市盈率为-19.09，贝塔值为 1.32。</p>
</div><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The company had revenue of $926.93 million during the quarter, compared to the consensus estimate of $889.83 million. During the same quarter in the prior year, the company posted ($0.25) EPS. The firm's revenue was up 47.5% on a year-over-year basis. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.</p>
<div class="lb-trans"><p>Alignment Healthcare（纳斯达克代码：ALHC - 获取免费报告）最近于 5 月 1 日（星期四）发布了季度财报。该公司报告的每股收益（EPS）为-0.05 美元，超过了市场共识预期的-0.12 美元，超出幅度为 0.07 美元。Alignment Healthcare 的股本回报率为-108.69%，净利润率为-5.84%。该公司在本季度的收入为 9.2693 亿美元，而市场共识预期为 8.8983 亿美元。在去年同期，该公司的每股收益为-0.25 美元。该公司的收入同比增长了 47.5%。股票研究分析师预测，Alignment Healthcare, Inc.在当前年度的每股收益将为-0.69 美元。</p>
</div><h2>Institutional Trading of Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的机构交易</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of ALHC. Wellington Management Group LLP lifted its position in Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company's stock worth $83,683,000 after acquiring an additional 3,257,630 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its position in shares of Alignment Healthcare by 54.7% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company's stock worth $97,302,000 after purchasing an additional 3,059,596 shares during the last quarter. Millennium Management LLC boosted its stake in Alignment Healthcare by 588.3% during the 4th quarter. Millennium Management LLC now owns 3,388,602 shares of the company's stock valued at $38,122,000 after purchasing an additional 2,896,311 shares during the period. Point72 Asset Management L.P. acquired a new stake in Alignment Healthcare in the 4th quarter valued at approximately $20,087,000. Finally, Invesco Ltd. grew its holdings in Alignment Healthcare by 1,415.7% in the 1st quarter. Invesco Ltd. now owns 1,875,790 shares of the company's stock valued at $34,927,000 after buying an additional 1,752,033 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近调整了对 ALHC 的持股。Wellington Management Group LLP 在第四季度将其在 Alignment Healthcare 的持股增加了 77.9%。Wellington Management Group LLP 目前持有 7,438,500 股该公司的股票，价值 83,683,000 美元，此前在上个季度增持了 3,257,630 股。T. Rowe Price Investment Management Inc.在第四季度将其在 Alignment Healthcare 的持股增加了 54.7%。T. Rowe Price Investment Management Inc.目前持有 8,649,042 股该公司的股票，价值 97,302,000 美元，此前在上个季度增持了 3,059,596 股。Millennium Management LLC 在第四季度将其在 Alignment Healthcare 的持股增加了 588.3%。Millennium Management LLC 目前持有 3,388,602 股该公司的股票，价值 38,122,000 美元，此前在该期间增持了 2,896,311 股。Point72 Asset Management L.P.在第四季度获得了 Alignment Healthcare 的新股份，价值约为 20,087,000 美元。最后，Invesco Ltd.在第一季度将其在 Alignment Healthcare 的持股增加了 1,415.7%。Invesco Ltd.目前持有 1,875,790 股该公司的股票，价值 34,927,000 美元，此前在上个季度增持了 1,752,033 股。目前 86.19% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>About Alignment Healthcare</h2>
<div class="lb-trans"><h2>关于 Alignment Healthcare</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.是一家技术驱动的医疗保险优势公司，为美国的老年人运营以消费者为中心的医疗保健平台。它通过其医疗保险优势计划提供定制的医疗保健，以满足各种老年人的需求。该公司成立于 2013 年，总部位于加利福尼亚州橙县。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Alignment Healthcare</li>
<li>NYSE Stocks Give Investors a Variety of Quality Options</li>
<li>These 4 Top Investors Bought Over 6 Million Broadcom Shares in Q1</li>
<li>3 Stocks to Protect Your Portfolio from the Coronavirus Contagion</li>
<li>Buy the Dip? 3 Oil Stocks Poised for a Big Comeback</li>
<li>What is the Hang Seng index?</li>
<li>Archer Rebuts Short Seller, Points to Strong Q1 &amp; Global Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更喜欢的五只股票超过 Alignment Healthcare</li>
<li>纽约证券交易所股票为投资者提供多种优质选择</li>
<li>这四位顶级投资者在第一季度购买了超过 600 万股博通股票</li>
<li>三只股票保护您的投资组合免受冠状病毒传播的影响</li>
<li>买入低位？三只油股有望大幅反弹</li>
<li>恒生指数是什么？</li>
<li>Archer 反驳空头，指出强劲的第一季度及全球势头</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前经过 MarketBeat 编辑团队的审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Alignment Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Alignment Healthcare 吗？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Alignment Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只股票，顶级分析师正在悄悄地向他们的客户推荐在更广泛的市场注意到之前购买……而 Alignment Healthcare 并不在名单上。</p>
</div><p>While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Alignment Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Alignment Healthcare (NASDAQ:ALHC) Trading Down 4.3% on Insider Selling

Alignment Healthcare（纳斯达克股票代码：ALHC）因内部人士出售股票而下跌 4.3%